Advancing Complex Biologics: Overcoming Challenges from Discovery to Clinic
Breakthrough biologics are transforming patient care, yet advancing these complex treatments from discovery to the clinic presents a unique set of challenges. Join top executives and innovators from pharma and biotech companies at this one-day event as they highlight the latest advancements in mRNA platforms, viral vectors, T-cell therapies, and sustainable bioprocesses.
Gain insights into novel approaches for cell line development, analytics for complex biologics, and AI-driven solutions that streamline the path from discovery to launch. Whether you're developing next-generation therapies or seeking strategic partnerships, this event tackles critical hurdles in bringing complex biologics into human trials and beyond.
Don't miss this opportunity to hear from experts shaping the future of biologics development.
Featured Sessions:
- Key Innovator Challenges in Bringing New Projects into the Clinic
- New Partners: Building a Global Biologics CDMO
- Moving Complex Biologics from Preclinical to First in Human
- Executive Interview: Innovator(s) on Challenges in Advancing New Treatments for Late Phase and Launch
Tech Talks:
- Harnessing Light for Precision manufacturing of Biopharmaceuticals
- Non-injectable delivery of Peptides and Biologics
- Innovation in Cell-based Assays for Cell and Gene Therapy
- Innovation in Complex Biologics Development
- Revolutionizing RNA Therapeutics Manufacturing with Enzymes
Benefits of Attending
Audience Networking
Q&A
